900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Meptazinol 100mg/mL injection solution 1mL ampule	Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Meptazinol 200mg tablet	Meptazinol (as meptazinol hydrochloride) 200 mg oral tablet
Mercurophylline injection	Mercurophylline
Merselene patch	Polyester mesh (physical object)
Mesalamine 250mg capsule	Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 250mg m/r capsule	Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 250mg prolonged-release oral capsule	Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 375mg m/r capsule	Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 375mg prolonged-release oral capsule	Product containing only mesalazine in oral dose form (medicinal product form)
Mesalazine 1g/100mL retention enema	Mesalazine only product in rectal dose form
Mesalazine 1g/100mL retention enema	Mesalazine only product in rectal dose form
Mesalazine 2g/59mL enema	Mesalazine only product in rectal dose form
Mesalazine 500mg/sachet gastro-resistant and prolonged-release oral granules	Product containing only mesalazine in oral dose form (medicinal product form)
Mesalazine 500mg/sachet m/r granules	Product containing only mesalazine in oral dose form (medicinal product form)
Mesalazine duplicate deleted	Product containing mesalazine (medicinal product)
Mesonephric tumor	Wolffian tumor of uncertain behavior (morphologic abnormality)
Mesoridazine besylate 10mg/mL injection solution ampule	Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Mesoridazine besylate 25mg/mL injection solution ampule	Product containing precisely mesoridazine 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Mesothelioma, biphasic, benign	Mesothelioma, benign
Metabolic acidosis caused by ingestion of drugs AND/OR chemicals	Metabolic acidosis
Metabolic disease, NEC	Metabolic disease
Metabolic function test NOS	Metabolic function test (procedure)
Metabolic function test NOS	Metabolic function test (procedure)
Metabolic marker	Inborn errors of metabolism marker
Metabolic monitoring NOS	Metabolic monitoring procedure
Metabolic monitoring NOS	Metabolic monitoring procedure
Metacarpal X-ray	Plain X-ray of metacarpal bone
Metacarpal X-ray	Plain X-ray of metacarpal bone
Metacarpal X-ray	Plain X-ray of metacarpal bone
Metaiodobenzylguanidine[123I] 74MBq/mL injection	Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[123I] 74MBq/mL powder for injection solution vial	Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I] 37MBq/mL injection	Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I] 37MBq/mL powder for injection solution vial	Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I]370MBq/mL injection	Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I]37MBq/mL diagnostic injection	Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I]9.25MBq/mL diagnostic injection	Iobenguane (131-I)-containing product in parenteral dose form
Metal engineering machiner NOS	Engineering machiner
Metal engineering machiner NOS	Engineering machiner
Metal processor/treater NOS	Metal processer
Metal processor/treater NOS	Metal processer
Metal production fitter NOS	Metal production fitter
Metal production fitter NOS	Metal production fitter
Metal/electrical worker NOS	Metal/electrical worker
Metal/electrical worker NOS	Metal/electrical worker
Metallocarboxypeptidase	Metallocarboxypeptidase
Metalloproteinase	Metalloproteinase
Metaproterenol 20mg tablet	Orciprenaline sulfate 20 mg oral tablet
Metaproterenol sulfate 0.65mg/inh aerosol	Orciprenaline only product in pulmonary dose form
Metaproterenol sulfate 15mg/mL aerosol	Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug)
Metastasis stage M1a	American Joint Committee on Cancer cM1a (qualifier value)
Metastasis stage M1b	American Joint Committee on Cancer cM1b (qualifier value)
Metastasis stage M1c	American Joint Committee on Cancer cM1c (qualifier value)
Metastasis stage M2	American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage M3	American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage M4	American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage pM1	American Joint Committee on Cancer pM1 (qualifier value)
Metastasizing pleomorphic adenoma	Pleomorphic adenoma
Metastatic apocrine adenocarcinoma to skin	Metastatic apocrine adenocarcinoma (disorder)
Metastatic carcinoid tumor	Metastatic well-differentiated neuroendocrine tumor (disorder)
Metastatic carcinoid tumor	Metastatic well-differentiated neuroendocrine tumor (morphologic abnormality)
Metastatic carcinoma to female breast	Metastatic carcinoma to breast
Metastatic carcinoma to male breast	Metastatic carcinoma to breast
Metastatic cholangiocarcinoma to biliary tract	Metastatic cholangiocarcinoma (morphologic abnormality)
Metastatic cholangiocarcinoma to perihilar bile duct	Metastatic cholangiocarcinoma
Metastatic collecting duct carcinoma to kidney	Metastatic collecting duct renal cell carcinoma (disorder)
Metastatic cystic renal cell carcinoma to kidney	Metastatic cystic renal cell carcinoma
Metastatic eccrine porocarcinoma to skin	Metastatic eccrine porocarcinoma
Metastatic infiltrating duct carcinoma to female breast	Metastatic infiltrating duct carcinoma to breast (disorder)
Metastatic lobular carcinoma to breast	Metastatic lobular carcinoma (disorder)
Metastatic lobular carcinoma to left female breast	Metastatic lobular carcinoma (disorder)
Metastatic lobular carcinoma to right female breast	Metastatic lobular carcinoma (disorder)
Metastatic malignant neoplasm to areola of female breast	Metastatic malignant neoplasm to areola (disorder)
Metastatic malignant neoplasm to areola of male breast	Metastatic malignant neoplasm to areola (disorder)
Metastatic malignant neoplasm to axillary tail of female breast	Metastatic malignant neoplasm to axillary tail of breast (disorder)
Metastatic malignant neoplasm to central portion of female breast	Metastatic malignant neoplasm to central portion of breast (disorder)
Metastatic malignant neoplasm to colon and/or rectum	Metastatic malignant neoplasm to cecum and/or colon and/or rectum (disorder)
Metastatic malignant neoplasm to ectopic female breast tissue	Metastatic malignant neoplasm to ectopic site of breast (disorder)
Metastatic malignant neoplasm to ectopic male breast tissue	Metastatic malignant neoplasm to ectopic site of breast (disorder)
Metastatic malignant neoplasm to female breast	Metastatic malignant neoplasm to breast (disorder)
Metastatic malignant neoplasm to lower inner quadrant of female breast	Metastatic malignant neoplasm to lower inner quadrant of breast (disorder)
Metastatic malignant neoplasm to lower outer quadrant of female breast	Metastatic malignant neoplasm to lower outer quadrant of breast
Metastatic malignant neoplasm to lymph node from primary malignant neoplasm of female breast	Metastatic malignant neoplasm to lymph node
Metastatic malignant neoplasm to male breast	Metastatic malignant neoplasm to breast (disorder)
Metastatic malignant neoplasm to nipple of female breast	Metastatic malignant neoplasm to nipple (disorder)
Metastatic malignant neoplasm to nipple of male breast	Metastatic malignant neoplasm to nipple (disorder)
Metastatic malignant neoplasm to upper inner quadrant of female breast	Metastatic malignant neoplasm to upper inner quadrant of breast
Metastatic malignant neoplasm to upper outer quadrant of female breast	Metastatic malignant neoplasm to upper outer quadrant of breast (disorder)
Metastatic pilomatrix carcinoma to skin	Metastatic pilomatrix carcinoma (disorder)
Metastatic renal cell carcinoma to kidney	Metastatic renal cell carcinoma
Metastatic renal cell carcinoma to kidney except renal pelvis	Metastatic renal cell carcinoma
Metatarsal phalangeal joint flap	Flap (substance)
Methacholine 2.5% eye drops	Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug)
Methacholine chloride 100mg powder	Product containing only methacholine (medicinal product)
Methadone 10mg/5mL mixture	Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug)
Methadone hydrochloride 40mg dispersible tablet	Product containing precisely methadone hydrochloride 40 milligram/1 each tablet for conventional release oral suspension (clinical drug)
Methamphetamine hydrochloride 10mg m/r tablet	Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 10mg prolonged-release oral tablet	Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 15mg m/r tablet	Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 15mg prolonged-release oral tablet	Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 5mg m/r tablet	Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 5mg prolonged-release oral tablet	Metamfetamine only product in oral dose form

Start Previous Page 114 of 235 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)